Blood schizontocidal activity of azithromycin and its combination with α/β arteether against multi-drug resistant Plasmodium yoelii nigeriensis, a novel MDR parasite model for antimalarial screening

Parasitology

Volumn 131, Issue 3, 2005, Pages 295-301

  Tripathi, R ^a   Dhawan, S ^b   Dutta, G P ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b CIMAP   (India)

Author keywords

arteether; Antibiotics; Antimalarial; Azithromycin; Malaria; Multi drug resistance; Plasmodium yoelii nigeriensis

Indexed keywords

AMODIAQUINE; ARTEETHER; AZITHROMYCIN; CHLOROQUINE; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; HALOFANTRINE; MEFLOQUINE; MEPACRINE; NORFLOXACIN; OXYTETRACYCLINE; QUININE; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; MALARIA; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; SCHIZONT;

ANIMALS; ANTIMALARIALS; ARTEMISININS; AZITHROMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; MICE; PARASITEMIA; PLASMODIUM YOELII;

CINCHONA PUBESCENS; PLASMODIUM YOELII NIGERIENSIS; RODENTIA;

EID: 24644506251     PISSN: 00311820     EISSN: None     Source Type: Journal    
DOI: 10.1017/S003118200500778X     Document Type: Article

References (35)

1. Andersen, S. L., Ager, A., Greevy, P. M. C., Scheuster, B. G., Wesche, D., Kuschmer, R., Ohrt, C., Ellis, W., Rossan, R. and Berman, J. (1995). Activity of azithromycin as a blood schizontocide against rodent and human plasmodia in vivo. American Journal of Tropical Medicine and Hygiene 52, 159-161.
2. Andersen, S. L., Oloo, A. J., Gordon, D. M., Ragama, O. B., Aleman, G. M., Berman, J. D., Tang, D. B., Dunne, M. W. and Shanks, G. D. (1998). Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and placebo-controlled field trial of azithromycin and doxycycline as prophylaxis, for malaria in western Kenya. Clinical Infectious Diseases 1, 146-150.
3. De Vries, P. I., Le, N. H., Le, T. D., Ho, P. L., Nguyen, V. N., Trinh, K. A. and Kager, P. A. (1999). Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence. Tropical Medicine and International Health 4, 407-408.
4. Degerli, K., Kilimcioglu, A. A., Kurt, O., Tamay, T. and Qzbilgin, A. (2003). Efficacy of azithromycin in a murine Toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey. Acta Tropica 88, 45-50.
5. Dutta, G. P. and Pande, A. (1986). Development of chloroquine resistance in experimental P. yoelii nigeriensis malaria in mice. Second National Conference of Parasitology, CDRI, Lucknow, p. 9 (abstract).
6. Dutta, G. P. and Singh, P. P. (1979). Blood schizontocidal activity of some antibiotics against Plasmodium knowlesi infection in Assamese monkey. Indian Journal Medical Research 70 (Suppl.), 91-94.
7. Dutta, G. P., Bajpai, R. and Vishwakarma, R. A. (1989). Antimalarial efficacy of arteether against multiple drug resistant strain of Plasmodium yoelii nigeriensis. Pharmacological Research 21, 415-419.
8. Geary, T. G. and Jensen, J. B. (1983). Effect of antibiotics on Plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene 32, 221-225.
9. Gingras, B. A. and Jensen, J. B. (1993). Activity of azithromycin (CP-62993) and erythromycin against chloroquine sensitive and chloroquine resistant strains of Plasmodium falciparum in vitro. American Journal of Tropical Medicine and Hygiene 47, 378-383.
10. Hill, J. (1975). The activity of some antibiotics and long acting compounds against the tissue stages of Plasmodium berghei. Annals of Tropical Medicine and Parasitology 69, 421-427.
11. Krudsood, S., Buchachart, K., Chalermrut, K., Charusabha, C., Treeprasertsuk, S., Haoharn, O., Duangdee, C. and Looareesuwam, S. (2002). A comparative clinical trial of combinations of dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 33, 525-531.
12. Krudsood, S., Silachamron, U., Wilairatana, P. Singhasivanon, P., Phumratanaprapin, W., Chalermrut, K., Phophak, N. and Popa, C. (2000). A randomized clinical trial of combinations of artesunate and azithromycin for treatment of uncomplicated Plasmodium falciparum malaria in Thailand. Southeast Asian Journal Tropical Medicine and Public Health 31, 801-807.
13. Lewis, C. (1968). Antiplasmodial activity of 7-halogenated lincomycins. Journal of Parasitology 54, 169-170.
14. Lode, H., Borner, K., Koeppe, P. and Schaberg, T. (1996). Azithromycin review of key chemical, pharmacokinetics and microbiological features. Antimicrobial Agents and Chemotherapy 37 (Suppl. C), 1-8.
15. Mahmoudi, N., Ciceron, L., Eranetich, J., Farhati, K., Silvie, O., Eling, W., Sauerwein, R., Danis, M., Mazier, D. and Derouin, F. (2003). In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp. Antimicrobial Agents and Chemotherapy 47, 2636-2639.
16. Na-Bangchang, K., Kanda, T., Tipawangso, P., Thanavibul, A., Suprakob, K., Ibrahim, M., Wattanagoon, Y. and Karbwang, J. (1996). Activity of artemether azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria. South East Asia Journal of Tropical Medicine and Public Health 3, 522-525.
17. National Antimalaria Programme (NAMP) Report. (2003). Directorate of the National Antimalaria Programme, Ministry of Health and Family Welfare (Government of India), New Delhi.
18. Peters, W. (1987). Chemotherapy and Drug Resistance in Malaria, 2nd Edn. Academic Press, London.
19. Peters, W., Jefford, C. W., Robinson, B. L. and Rossier, J. C. (1993a). The chemotherapy of rodent malaria. XLIX. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine resistant parasites. Part 2: Structure activity studies on cis-fused cyclopenteno-1,2,4- trioxanes (fenozans) against drug-sensitive and drug-resistant lines of P. berghei and P. yoelii sp. in vivo. Annals of Tropical Medicine and Parasitology 87, 9-16.
20. Peters, W., Robinson, B. L., Rossier, J. C. and Jefford, C. W. (1993). The chemotherapy of rodent malaria. XLVIII. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine resistant parasites. Part 1: Studies leading to the development of novel cis-fused bicyclic cyclopenteno derivatives. Annals of Tropical Medicine and Parasitology 87, 1-7.
21. Peters, W., Robinson, B. L., Tovey, G., Rossier, J. C. and Jefford, C. W. (1993c). The chemotherapy of rodent malaria. L. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine resistant parasites. Part 3: Observations on 'Fenozan-50 F,' a difluorinated 3,3-spirocyclopentane 1,2,4 trioxane. Annals of Tropical Medicine and Parasitology 87, 111-123.
22. Puri, S. K. and Dutta, G. P. (1982). Antibiotics in the chemotherapy of malaria. Progress in Drug Research 26, 167-205.
23. Puri, S. K. and Dutta, G. P. (1989). Spectrum of the antimalarial activity of a new microlide antibiotic midecamycin in mice and monkeys. Chemotherapy 35, 187-197.
24. Puri, S. K. and Singh, N. (2000). Azithromycin: Antimalarial profile against blood and sporozite-induced infections in mice and monkeys. Experimental Parasitology 94, 8-14.
25. Remme, J. H. F., Bias, E., Chitsulo, L. Desjeux, P. M. P., Engers, H. D., Kanyok, T. P., Kayondo, J. F. K., Kioy, D. W., Kumaraswami, V., Lazdins, J. K., Nunn, P. P., Oduola, A., Ridley, R. G., Joure, Y. T., Zicker, F. and Morel, C. M. (2002). Strategic emphasis for tropical disease research: a TDR prespective. Trends in Parasitology 18, 421-442.
26. Sharma, V. P. (1998). Roll back malaria. Current Science 75, 756-757.
27. Singh, N. and Puri, S. K. (1996). Blood schizontocidal profile of fluoroquinolone antibiotics against chloroquine resistant murine malaria. Journal of Parasitic Diseases 20, 45-48.
28. Strath, M., Finnigan, T. S., Gardner, M., Williamson, D. and Wilson, I. (1993). Antimalarial activity of rifampicin in vitro and in rodent models. Transactions of the Royal Society Tropical Medicine Hygiene 87, 211-216.
29. Taylor, W. R., Ritchie, T. L., Fryauff, D. J., Picarima, H., Ohrt, C., Tang, D., Braitman, D., Murphy, G. S., Widjaja, H., Tjitra, E., Ganjar, A., Jones, T. R., Baeri, H. and Berman, J. (1999). Malaria prophylaxis using azithromycin a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clinical Infectious Diseases 28, 74-81.
30. Taylor, W. R., Ritchie, T. L., Fryauff, D. J., Ohrt, C., Picarima, H., Tang, D., Murphy, G. S., Widjaja, H., Braitman, D., Tjitra, E., Ganjar, A., Jones, T. R., Basri, H. and Berman, J. (2003). Tolerability of azithromycin as malaria prophylaxis in adults in Northeast Papua, Indonesia. Antimicrobial Agents and Chemotherapy 47, 2199-2203.
31. Tarlow, M. J., Block, S. L., Harris, J. and Kolokathis, A. (1997). Future indications for macrolides. Pediatric Infection Disease Journal 16, 457-462.
32. Tripathi, K. D., Sharma, A. K., Valecha, N. and Biswas, S. (1993). In vitro activity of fluoroquinolones against chloroquine resistant and chloroquine sensitive P. falciparum. Indian Journal of Malariology 30, 67.
33. World Health Organization (1999). Removing obstacles to healthy development. WHO Report on Infectious Diseases. World Health Organization, Geneva.
34. Yeo, A. E. and Rieckmann, K. H. (1995). Increased antimalarial activity of azithromycin during prolonged exposure of Plasmodium falciparum in vitro. International Journal for Parasitology 4, 531-532.
35. Zuckerman, J. M. and Kaye, K. M. (1995). The newer macrolides. Infecious Disease Clinics of North America 731-745.